What Are the Challenges in Targeting This Pathway?
One of the main challenges is the development of resistance to SMO inhibitors, often due to mutations in SMO or activation of alternative pathways that bypass SMO. Another challenge is the potential toxicity and side effects, as the Hedgehog pathway is also involved in normal tissue homeostasis. Therefore, there is a need for more selective and effective inhibitors.
